SCHEMBL7450801

SCHEMBL7450801

O=C(O)Cc1ccc(Nc2ccccc2)nc1

nearest known ligand 0.59

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HCAR3 P49019 1/20 0.59
JAK2 O60674 3/20 0.52
JAK1 P23458 3/20 0.52
TYK2 P29597 3/20 0.52
JAK3 P52333 3/20 0.52
GABRP O00591 1/20 0.51
GABRD O14764 1/20 0.51
GABRA1 P14867 1/20 0.51
GABRB1 P18505 1/20 0.51
GABRG2 P18507 1/20 0.51
GABRB3 P28472 1/20 0.51
GABRA5 P31644 1/20 0.51
GABRA3 P34903 1/20 0.51
GABRA2 P47869 1/20 0.51
GABRB2 P47870 1/20 0.51
GABRA4 P48169 1/20 0.51
GABRE P78334 1/20 0.51
GABRA6 Q16445 1/20 0.51
GABRG1 Q8N1C3 1/20 0.51
GABRG3 Q99928 1/20 0.51

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9074229 0.81 HCAR3 (0.56) HCAR3JAK2JAK1TYK2JAK3
SCHEMBL11264933 0.79 KMT2A (0.55) LMNAMEN1KMT2AAKR1B1PDE4B
SCHEMBL23833540 0.78 GABRP (0.61) JAK2JAK1TYK2JAK3GABRP
SCHEMBL30094658 0.78 GABRP (0.61) JAK2JAK1TYK2JAK3GABRP
SCHEMBL152586 0.78 HCAR3 (0.51) HCAR3MAPTLMNAMEN1KMT2A
SCHEMBL28056250 0.78 HCAR3 (0.51) HCAR3JAK2JAK1TYK2JAK3
SCHEMBL8545034 0.78 HCAR3 (0.51) HCAR3JAK2JAK1TYK2JAK3
SCHEMBL3981252 0.75 PTK2 (0.56) HCAR3JAK2JAK1TYK2JAK3
SCHEMBL71308 0.75 HCAR3 (1.00) HCAR3MAPTLMNAMEN1KMT2A
SCHEMBL12462388 0.73 HSD17B10 (0.60) GABRPGABRDGABRA1GABRB1GABRG2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1242076-A4 2-BENZYL AND 2-HETEROARYL BENZIMIDAZOLE NMDA/NR2B ANTAGONISTS MERCK & CO INC (US) 2002-11-27 EP disclosed
EP-1242076-A1 2-BENZYL AND 2-HETEROARYL BENZIMIDAZOLE NMDA/NR2B ANTAGONISTS Merck & Co., Inc. (US) 2002-09-25 EP disclosed
US-6316474-B1 TREATMENT OF PAIN, SCHIZOPHRENIA, PARKINSON'S DISEASE, STROKE AND DEPRESSION MERCK & CO., INC. 2001-11-13 US disclosed
WO-2001032174-A1 2-BENZYL AND 2-HETEROARYL BENZIMIDAZOLE NMDA/NR2B ANTAGONISTS MERCK & CO., INC. (US) 2001-05-10 WO disclosed